Skip to main content
Gut logoLink to Gut
letter
. 1988 May;29(5):693–694. doi: 10.1136/gut.29.5.693-b

Lymphokine activated killer cell activity in patients with GI cancer.

P O'Byrne
PMCID: PMC1433633  PMID: 3396957

Full text

PDF
693

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burdette S., Schwartz R. S. Current concepts: immunology. Idiotypes and idiotypic networks. N Engl J Med. 1987 Jul 23;317(4):219–224. doi: 10.1056/NEJM198707233170407. [DOI] [PubMed] [Google Scholar]
  2. Holmes E. C. Immunology of tumor infiltrating lymphocytes. Ann Surg. 1985 Feb;201(2):158–163. doi: 10.1097/00000658-198502000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. North R. J. Down-regulation of the antitumor immune response. Adv Cancer Res. 1985;45:1–43. doi: 10.1016/s0065-230x(08)60265-1. [DOI] [PubMed] [Google Scholar]
  4. Vose B. M., Moore M. Human tumor-infiltrating lymphocytes: a marker of host response. Semin Hematol. 1985 Jan;22(1):27–40. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES